CLYM – climb bio, inc. (US:NASDAQ)
Stock Stats
News
Climb Bio (CLYM) had its price target raised by Robert W. Baird from $9.00 to $12.00. They now have an "outperform" rating on the stock.
Climb Bio (CLYM) is now covered by Wedbush. They set an "outperform" rating and a $12.00 price target on the stock.
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates 
Climb Bio (NASDAQ:CLYM) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
Form S-8 Climb Bio, Inc.
Form 10-K Climb Bio, Inc. For: Dec 31
Form 8-K Climb Bio, Inc. For: Mar 05
Form 4 Climb Bio, Inc. For: Feb 25 Filed by: Thomas Stephen Basil
Form 144 Climb Bio, Inc. Filed by: Thomas Stephen Basil
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.